Natco Pharma Ltd
NSE: NATCOPHARM BSE: 524816
₹959.20
(2.25%)
Sat, 21 Mar 2026, 02:37 pm
Market Cap171.56B
PE Ratio11.03
Dividend0.52
Health Technology
Pharmaceuticals: Major
24.5KNatco Pharma Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.68B | 2.42B | 3.27B | 4.38B | 4.57B | 4.56B | 5.16B | 6.17B | 7.00B | 7.85B | 10.27B | 19.97B | 21.59B | 20.65B | 18.93B | 16.93B | 19.07B | 26.99B | 39.81B | 44.15B |
| Gross profit | 402.42M | 592.24M | 583.11M | 1.23B | 1.19B | 1.39B | 1.55B | 1.65B | 2.17B | 2.62B | 4.49B | 10.00B | 12.67B | 10.29B | 9.18B | 5.73B | 6.30B | 12.01B | 22.92B | 26.38B |
| Operating expenses (excl. COGS) | -352.98M | -362.80M | -141.52M | -647.99M | -494.83M | -604.95M | -658.22M | -699.76M | -1.06B | -1.32B | -2.23B | -3.60B | -4.14B | -3.02B | -4.43B | -4.21B | -5.24B | -3.96B | -6.58B | -5.76B |
| Selling/general/admin expenses, total | -287.04M | -300.59M | -47.05M | -686.56M | -407.14M | -509.70M | -596.41M | -626.70M | -950.23M | -1.19B | -2.29B | -3.65B | -3.90B | -2.64B | -4.07B | -3.87B | -4.90B | -3.69B | -5.05B | -5.28B |
| Research & development | -11.08M | -18.77M | -47.05M | -229.71M | -77.89M | -110.46M | -84.27M | -146.34M | -142.85M | -126.08M | -552.00M | -910.00M | -1.28B | -1.69B | -1.54B | -1.43B | -2.21B | -892.00M | -1.21B | -1.04B |
| Selling/general/admin expenses, other | -275.96M | -281.82M | — | -456.86M | -329.25M | -399.24M | -512.13M | -480.36M | -807.38M | -1.07B | -1.74B | -2.74B | -2.62B | -956.00M | -2.52B | -2.44B | -2.69B | -2.80B | -3.84B | -4.24B |
| Other operating expenses, total | -65.93M | -62.21M | -94.47M | 38.57M | -87.69M | -95.25M | -61.82M | -73.06M | -107.61M | -130.83M | 59.00M | 56.00M | -247.00M | -380.00M | -366.00M | -340.00M | -341.00M | -269.00M | -1.53B | -475.00M |
| Operating income | 49.44M | 229.44M | 441.59M | 585.00M | 695.21M | 785.16M | 890.87M | 945.33M | 1.11B | 1.29B | 2.26B | 6.40B | 8.53B | 7.27B | 4.74B | 1.52B | 1.06B | 8.05B | 16.33B | 20.62B |
| Non-operating income, total | 216.92M | 179.86M | 113.34M | -22.89M | -60.61M | -133.93M | -95.45M | 77.87M | 179.74M | 49.24M | -242.00M | -156.00M | 345.00M | 981.00M | 946.00M | 4.27B | 963.00M | 567.00M | 402.00M | 2.30B |
| Interest expense, net of interest capitalized | -69.64M | -56.88M | -85.05M | -137.95M | -130.37M | -124.89M | -211.80M | -263.07M | -366.19M | -316.76M | -229.00M | -185.00M | -154.00M | -193.00M | -215.00M | -133.00M | -177.00M | -145.00M | -192.00M | -183.00M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 82.66M | 67.24M | 10.06M | 11.02M | 20.83M | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 286.88M | 239.90M | 199.35M | 124.94M | 69.79M | -8.54M | 126.74M | 493.82M | 546.42M | 517.98M | -38.00M | 53.00M | 494.00M | 1.17B | 1.16B | 1.04B | 790.00M | 787.00M | 549.00M | 2.85B |
| Non-operating interest income | 131.80M | 13.89M | 72.26M | 9.29M | 8.44M | 2.21M | 24.87M | 23.51M | 25.02M | 6.56M | 55.00M | 79.00M | 249.00M | 898.00M | 791.00M | 566.00M | 390.00M | 512.00M | 1.01B | 1.87B |
| Miscellaneous non-operating expense | 155.09M | 226.02M | 127.09M | 115.66M | 61.35M | -10.75M | 101.86M | 470.31M | 521.40M | 511.42M | -93.00M | -26.00M | 245.00M | 276.00M | 370.00M | 478.00M | 400.00M | 275.00M | -461.00M | 975.00M |
| Unusual income/expense | -321.35K | -3.17M | -962.74K | -9.88M | -23.76K | -500.36K | -10.39M | -152.89M | -494.05K | -151.98M | 25.00M | -24.00M | 5.00M | 0 | 0 | 3.36B | 350.00M | -75.00M | 45.00M | -367.00M |
| Pretax income | 266.37M | 409.30M | 554.93M | 562.11M | 634.60M | 651.23M | 795.42M | 1.02B | 1.29B | 1.34B | 2.02B | 6.24B | 8.87B | 8.25B | 5.69B | 5.80B | 2.02B | 8.62B | 16.73B | 22.91B |
| Taxes | -24.32M | -92.04M | -139.04M | -108.60M | -139.66M | -132.11M | -210.75M | -364.36M | -308.70M | -39.50M | -479.00M | -1.40B | -1.92B | -1.82B | -1.11B | -1.37B | -322.00M | -1.47B | -2.85B | -4.08B |
| Non-controlling/minority interest | -4.11M | -12.64M | -10.75M | -13.79M | 7.70M | 15.99M | 11.41M | 59.86M | 46.28M | 43.49M | 13.00M | 11.00M | 10.00M | 20.00M | 27.00M | -15.00M | 0 | 0 | 0 | 20.00M |
| After tax other income/expense | 0 | 0 | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 237.93M | 304.63M | 405.14M | 439.72M | 502.64M | 535.11M | 596.08M | 718.69M | 1.03B | 1.35B | 1.55B | 4.86B | 6.96B | 6.44B | 4.61B | 4.41B | 1.70B | 7.15B | 13.88B | 18.85B |
| Net income | 237.93M | 304.63M | 405.14M | 439.72M | 502.64M | 535.11M | 596.08M | 718.69M | 1.03B | 1.35B | 1.57B | 4.86B | 6.96B | 6.44B | 4.61B | 4.41B | 1.70B | 7.15B | 13.88B | 18.85B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 237.93M | 304.63M | 405.14M | 439.72M | 502.64M | 535.11M | 596.08M | 718.69M | 1.03B | 1.35B | 1.57B | 4.86B | 6.96B | 6.44B | 4.61B | 4.41B | 1.70B | 7.15B | 13.88B | 18.85B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 152.45M | 334.31M | 535.08M | 725.58M | 892.54M | 943.98M | 1.05B | 1.17B | 1.41B | 1.77B | 2.77B | 6.94B | 9.19B | 8.08B | 5.74B | 2.69B | 2.48B | 9.69B | 18.20B | 22.47B |
| EBIT | 49.44M | 229.44M | 441.59M | 585.00M | 695.21M | 785.16M | 890.87M | 945.33M | 1.11B | 1.29B | 2.26B | 6.40B | 8.53B | 7.27B | 4.74B | 1.52B | 1.06B | 8.05B | 16.33B | 20.62B |
| Total operating expenses | -1.63B | -2.19B | -2.83B | -3.80B | -3.87B | -3.77B | -4.27B | -5.23B | -5.89B | -6.55B | -8.02B | -13.57B | -13.06B | -13.38B | -14.19B | -15.41B | -18.01B | -18.94B | -23.48B | -23.53B |
| Prepaid expenses | 86.32M | 112.63M | 127.64M | 544.36M | 43.21M | 80.86M | 157.96M | 15.56M | 18.67M | 38.17M | 65.00M | 74.00M | 125.00M | 139.00M | 180.00M | 226.00M | 326.00M | 283.00M | 289.00M | 305.00M |
| Deferred income, current | — | — | — | — | — | — | — | — | 151.95M | 202.20M | 237.00M | 144.00M | 184.00M | 189.00M | 4.00M | 13.00M | 30.00M | 862.00M | 853.00M | 828.00M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 2.06M | 898.31K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.00M | 9.00M | 80.00M | 11.00M | 53.00M | 46.00M |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 172.36M | 190.48M | 215.36M | 240.89M | 268.34M | 269.49M | 313.98M | 472.36M | 430.57M | 118.89M | 207.00M | 160.00M | 146.00M | 116.00M | 259.00M | 413.00M | 301.00M | 124.00M | 2.00M | 2.00M |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — |
| Minority interest | 59.87M | 57.26M | 68.01M | 69.51M | 49.40M | 10.59M | 8.84M | 105.37M | 68.80M | 50.25M | 49.00M | 41.00M | 38.00M | 20.00M | 112.00M | 18.00M | 0 | 0 | 0 | 53.00M |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -32.86M | -33.45M | -33.99M | -80.33K | -106.42M | -65.22M | -106.72M | -143.58M | -193.49M | -199.33M | -261.00M | -1.41B | -1.81B | -1.11B | -1.54B | -1.14B | -822.00M | -1.00B | -1.71B | -1.08B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800